Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by princeofcuton May 13, 2015 8:32am

102 Views

Post# 23722900

RE:RE:RE:RE: Zeinth web cast

GV, i will be surprised if there are questions..no "analyst" will as Zenith is not a listed company..will they take Questions from actual Zenith owners who knows, but i doubt they will as fraudsters like leftcoast will ask RVX Questions and why would DM open Zenith up to that...the big owners of Zenith know exactly what is going on...there is a pump purpose to the webcast no more no less, he wants to sell us "retail" owners of Zenith on something.. still a possiblity of rolling Zenith back into RVX to right the stupidity of the separation and this call is to prep that..IMO

Bullboard Posts

Looking at: Is Taylor Swift the key to solving traffic in Toronto?